Finally, immunohistochemical analyses of NSCLC tissue microarrays (TMAs) show that expression of nuclear HIC1 in para-carcinoma was 52.2%, while its expression in carcinoma was only 15.4% (Supplementary Figure 3). The gene discussed is HIC1; the disease is carcinoma.